SIRT5 and prostate cancer: In addition to our current results in gastric cancer, previous studies have also shown that ACAT1 expression levels in prostate cancer are higher compared to adjacent normal tissues, with ACAT1 and SIRT5 synergistically promoting the development of invasive prostate cancer (38).